reast augmentation is the second most common aesthetic surgery procedure performed by plastic surgeons in the United States, second only to liposuction. There are over 305,000 breast augmentations performed yearly, for a total U.S. market expenditure of over $1 billion.
life-threatening complications were exceedingly rare. 3 Of more utility in this patient population is the evaluation of changes in quality of life, body image, patient satisfaction, and self-esteem. Such constructs are best measured from the patient perspective using breast surgery-specific patientreported outcome instruments.
Because generic patient-reported outcome instruments do not ask about breast-specific concerns, validated breast-specific patient-reported outcome questionnaires are needed to ensure that meaningful before and after data relevant to a given intervention are collected. 4 One of the most widely used breast surgery patient-reported outcome questionnaires, the BREAST-Q, is a rigorously designed, well-validated, disease-specific patient-reported outcome instrument that has now been used in research with over 22,000 women having different types of breast surgery. [5] [6] [7] [8] [9] [10] The BREAST-Q has modules for different types of breast surgery, each with questions specific to that subset of breast surgery, including a module with questions designed specifically for patients undergoing breast augmentation. 11 The BREAST-Q Augmentation module has been used to compare preoperative and postoperative outcomes in women undergoing breast augmentation, with consistent postaugmentation improvements in satisfaction and well-being. 2, 10, 12, 13 A current limitation of the BREAST-Q Augmentation module is a lack of normative scores for breast satisfaction and well-being of women in the general population. Therefore, although the BREAST-Q has been used to demonstrate the efficacy of breast augmentation, it is not yet known how these preoperative and postoperative patients, with regard to breast satisfaction and well-being, compare to population norms. The primary aim of this study was to generate normative scores for the BREAST-Q Augmentation module. The secondary aim was to compare these normative scores to published BREAST-Q scores for breast augmentation, in efforts to bring greater clinical context to previously determined findings.
SUBJECTS AND METHODS

Study Population
The Army of Women is an online community of women (breast cancer patients and healthy women), with a primary goal of promoting breast cancer-related research. The Army of Women was started in 2008 by the Dr. Susan Love Research Foundation. Before using the Army of Women community for study recruitment, the Scientific Advisory Committee at the Army of Women accepted the study, and institutional review board waiver was obtained from Dartmouth College's Committee for the Protection of Human Subjects. An electronic recruitment e-mail (e-blast) was circulated to Army of Women members with a short study description and the following inclusion criteria: age 18 years or older, no history of breast cancer or breast surgery, and the ability to complete a questionnaire online, in English.
Recruitment
The e-blast describing the study was sent to 121,688 Army of Women members. Army of Women members who were interested and selfselected to meet inclusion criteria followed the e-blast to complete a module of the BREAST-Q. The BREAST-Q was administered using Qualtrics (Qualtrics, LLC, Provo, Utah), an online Webbased software for questionnaire administration. Participants were recruited as part of a study to generate normative scores for three different modules of the BREAST-Q: Augmentation, Reduction, and Reconstruction. All participants were also asked to provide demographic information, bra cup size, height, and weight. An algorithm was written into the Qualtrics link to automatically reroute participants to the next BREAST-Q module once 1200 participants had completed one of the modules. The algorithm started with the Reduction module, followed by the Augmentation and then the Reconstruction modules. Normative data for the two other BREAST-Q modules will be published separately.
BREAST-Q
The BREAST-Q, developed for all types of breast surgery, is a rigorously developed and wellvalidated patient-reported outcome instrument with an Augmentation module designed specifically for the evaluation of outcomes in patients seeking and undergoing breast augmentation. 6, 9, 11 The development of the conceptual framework and set of scales involved a literature review, 48 patient interviews, 46 cognitive patient interviews, and expert opinion from a panel of plastic surgeons and other health care professionals (phase 1). The BREAST-Q was tested in a sample of 401 patients, which included 174 preaugmentation and 227 postaugmentation patients. 14, 15 The BREAST-Q Augmentation module has four preoperative scales: Satisfaction with Breasts (n = 6 items), Psychosocial Plastic and Reconstructive Surgery • April 2017
Well-being (n = 9 items), Sexual Well-being (n = 5 items), and Physical Well-being (n = 5 items). Scale items are summed and transformed on a scale from 0 (worst) to 100 (best) using the Q-Score (Rasch Unidimensional Measurement Models Laboratory, Perth, Australia) program (New York, N.Y.). In the BREAST-Q development sample (n = 401), scales had Cronbach alpha scores between 0.81 and 0.94, item total correlations from 0.55 to 0.82, and testretest reliability (n = 68) with intraclass correlation coefficients between 0.85 and 0.94.
Statistical Analysis
Descriptive statistics were computed, including the mean, standard deviation, and a 95 percent confidence interval for continuous variables, with percentages listed for categorical variables. A primary analysis was performed with a backwardselection linear multivariate regression to identify variables associated with BREAST-Q scores. All variables were converted into dichotomous variables as follows: body mass index greater than or equal to 30 kg/m 2 versus body mass index less than 30 kg/m 2 ; age greater than or equal to 40 years versus age younger than 40 years; bra size greater than or equal to D versus less than D; ethnicity, white non-Hispanic versus other; education, college degree or higher versus less than college degree; employment, full-time versus other than full-time; income, greater than or equal to $40,000 versus less than $40,000 per year; and marital status, married versus other. Binomial variables with a probability of less than 0.2 were rejected and removed from the model, and the model was rerun with only the significant variables (p < 0.05). Data analysis was performed using Stata/SE 11.0 (StataCorp, College Station, Texas).
Once normative data had been generated, a separate analysis compared the normative scores to previously published BREAST-Q data using 95 percent confidence intervals. Previously published studies were identified by electronic literature search in PubMed (January of 2016) using "BREAST-Q" and "BREASTQ" as search terms, and then manually evaluating publications for studies using the Augmentation module of the BREAST-Q. Data from each identified study were extracted, including study design, sample size, and BREAST-Q scores. Authors were contacted for additional information as needed. The selected studies were the largest sample size with complete data. From each publication, the sample size and BREAST-Q mean score and standard deviation were used to calculate a 95 percent confidence interval.
RESULTS
At the time of the e-blast, there were 121,688 members in the Army of Women. A second e-blast was circulated 3 months after the first, to generate the remaining 409 participants needed to reach the study minimum of 3600 for all three BREAST-Q modules. There were 4326 women who selfselected to meet study inclusion criteria, with 3618 women completing the study. In addition, there were 142 not included in the study who attempted to participate after capacity was reached yet before the Army of Women closed the study. The overall response rate across the study was 87 percent. Of the respondents, a total of 1211 women completed the BREAST-Q Augmentation module preoperative questionnaire.
For the Augmentation sample, the mean age was 54 ± 24 years, the mean body mass index was 27 ± 6, and 39 percent had a bra cup size of D or greater (n = 467). Women were primarily nonHispanic white (89 percent) and married (70 percent). Gross household income was $100,000 or greater in 45 percent of participants. A chronic health condition was reported in 43 percent (n = 521), with commonly cited conditions as follows: hypothyroidism, diabetes, hypertension, hyperlipidemia, asthma, gastroesophageal reflux disease, inflammatory bowel disease, irritable bowel syndrome, arthritis, psoriasis, and headaches. The remaining demographic data are listed in Table 1 .
The normative scores are listed in Table 2 . Specific instructions for the Sexual Well-being scale stated that items should not be completed if the participant was uncomfortable with the content or felt the items were not applicable. These instructions are consistent with the instructions for the BREAST-Q. A total of 1092 participants completed the Sexual Well-being scale.
The linear multivariate regression models for the four BREAST-Q scales generated between two and four variables (body mass index, bra cup size, age, education, employment status, and the presence of a chronic disease) that were associated with the augmentation scale scores. Women with a body mass index of 30 kg/m 2 or greater, and women with a bra cup size of D or greater, had lower BREAST-Q scores compared with reference groups of those with a body mass index less than 30 kg/m 2 and bra cup size less than D across all four augmentation scales. The remaining significant variables using a 95 percent confidence interval are detailed in Figure 1 .
The literature search revealed eight studies for data comparison. A study published in 2014 by Alderman et al. was selected, along with data from the Breast Implant Follow-up Study published in 2016, as these were the largest studies using both preoperative and postoperative augmentation questionnaires.
2, 16 Alderman et al. collected data at three time points: preoperatively, 6 weeks postoperatively, and 6 months postoperatively.
Data from 218 patients from the preoperative and 6-week postoperative time points are used here for comparison. The Breast Implant Follow-up Study authors collected Satisfaction with Breasts and Psychosocial Well-being data preoperatively, 1 year postoperatively, and 4 years postoperatively for 12,726 patients with silicone implants and 1788 patients with saline implants. Figure 2 outlines the comparison between the Alderman et al. data, the Breast Implant Followup Study data, and the normative scores. With 95 percent confidence intervals, for Satisfaction with Breasts, Psychosocial Well-being, and Sexual Wellbeing, preoperative scores are lower than normative scores, and postoperative scores are higher than normative scores. Physical Well-being preoperative scores are higher than the norm, and 6-week postoperative scores are lower than both preoperative scores and the norm, also with 95 percent confidence intervals.
DISCUSSION
The utility of patient-reported outcome questionnaires, and a focus on patient-centered data, evaluating quality of life, well-being, self-esteem, and body image, is well established for the breast augmentation population. However, although some studies using ad hoc or generic quality-oflife questionnaires have demonstrated global differences in these variables for women presenting for breast augmentation in comparison with population controls, 17, 18 not all studies have found this to be the case. 19 It was instead lower breast-specific quality of life and well-being, in the setting of an overall unchanged body image and selfesteem, that has been shown in these women. 20 These findings highlight the importance of using a disease-specific patient-reported outcome questionnaire to measure outcomes that matter to this patient population. The BREAST-Q does just this, generating objective, reliable, and valid patientcentered data that are clinically relevant to breast augmentation patients.
The BREAST-Q Augmentation module has been used successfully in a number of studies. 10 Coriddi et al. evaluated 49 patients before surgery Plastic and Reconstructive Surgery • April 2017 and 6 weeks after surgery, and demonstrated improvements in satisfaction with breasts, and psychosocial, sexual, and physical well-being. 13 Alderman et al., as discussed earlier, demonstrated improvements in all scales except Physical
Well-being at 6 weeks postoperatively, with even greater improvements at 6 months postoperatively in 611 patients. 2 McCarthy et al. studied 41 patients at preoperative and postoperative time points, demonstrating an improvement in satisfaction, and psychosocial and sexual wellbeing, and quantifying the effect size of breast augmentation. The authors reported an effect size of 2.4 for Satisfaction with Breasts, similar to other common surgical procedures, such as hip arthroplasty, with a reported effect size of 3.1.
12 Although these studies have demonstrated the efficacy and added value of breast augmentation surgery to patients, placing the findings into the context of normative data has been missing. The normative scores presented here provide increased clinical context for the interpretation of the data previously published.
Within our study population, there were certain patient and demographic factors associated with differences in generated augmentation scores. Women who were obese and women with larger breast sizes reported lower BREAST-Q scores compared with women who were not obese and women with smaller breasts. As women presenting for augmentation tend to be smaller than the general population in both body and bra cup size, 18 it is possible that a "true" normative score for comparison in this population is likely higher than that presented here. In addition, in the normative sample, younger women reported lower Psychosocial Well-being scores compared with older women. It is possible that over time, without surgical intervention, women may develop increased psychosocial well-being with regard to their breasts.
In applying our findings to previously published studies in the literature, it is apparent that women presenting for augmentation, with the exception of Physical Well-being, have lower preoperative scores than the norm. This supports the belief that there may be actual clinical differences in how women seeking augmentation perceive their breasts, justifying the motivations for pursuing surgery. These are not simply women looking to make "normal" better, as some might infer, but are women who perceive themselves to have a significant psychological or emotionally oriented burden associated with their breasts, that can be addressed by breast augmentation. Furthermore, postoperative scores were significantly higher than the mean, suggesting that breast augmentation not only corrects the perceived deficit experienced by these women, but also results in substantial breast-related quality-of-life gains in comparison with a population control. The exception to these findings was the Physical Well-being data presented in the study by Alderman et al. Preoperative scores were higher than the mean, and scores obtained 6 weeks postoperatively were lower than the mean. However, at 6 months postoperatively, Physical Well-being scores increased to close to the normative scores, suggesting that additional follow-up time may be needed to fully establish the relationship between breast augmentation and physical well-being. This is the first study to generate normative data for the BREAST-Q Augmentation module. Of particular strength is the large sample size, with over 1200 women. Furthermore, there was diversity in the ages of women completing the questionnaire. In addition, there was a focus on women with smaller breasts, as over 60 percent of participants had bra cup sizes of C or less, which is similar to many of the patients presenting for augmentation. Lastly, the normative scores reported here can be easily compared to current and future data generated with the BREAST-Q both by researchers and by clinicians.
The primary limitation of this study is reflective of the study population that completed the questionnaire. Women who are part of the Army of Women are motivated individuals, looking to donate their time and energy to the promotion of health outcomes research, typically as it relates to breast cancer prevention and treatment. There is a significant lack of racial diversity in the Army of Women, as less than 15 percent of participants completing this study were an ethnicity other than non-Hispanic white. In addition, a high proportion of participants were highly educated and of a higher income status. Although these factors are not representative of a random U.S. population, and are thus limitations to our research, they are similar to previously published data on the BREAST-Q 10 and large studies using the Army of Women, 21 and are common limitations faced in large clinical trials. 22 In addition, the women in the Army of Women had a greater age and body mass index compared with women in the augmentation literature. This is a limitation of our data, as both age and body mass index impact BREAST-Q Augmentation scores. Furthermore, the normative data presented here are not stratified by geographic location within the United States. As rates of augmentation vary across geographic region, it is possible that normative values also vary; thus, this is a limitation in our results. We were able to identify a cohort of 125 women of younger age and lower body mass index; however, we hesitate to call these normative data. Nonetheless, their scores to not appear to differ widely from the mean ± SD scores for the lateral cohort: Satisfaction with Breasts (55 ± 20), Psychosocial Wellbeing (65 ± 18), Sexual Well-being (54 ± 16), and
Plastic and Reconstructive Surgery • April 2017
Physical Well-being Chest (88 ± 13). Additional limitations relate to the online administration of the questionnaire, as participants self-selected and a practitioner did not verify eligibility criteria. In addition, although the strength of using the Army of Women sample to conduct research is its speed and low cost of accrual, the population norms were generated primarily on U.S. women and may not be generalizable outside the United States.
In the data collection phase, an algorithm automatically routed interested participants to complete a given preoperative BREAST-Q module until the module had reached 1200 responses, before automatically routing to the next module. This method of completing the modules in series, as opposed to randomly assigning participants to module completion, may explain the slight variances in demographic values and BREAST-Q scores observed between the three separate preoperative normative data sets.
Limitations can also be attributed to the published study selected for comparison. The study bu Alderman et al. is the largest study to date using the complete BREAST-Q Augmentation module for both preoperative and postoperative data collection. However, this is only one study and is likely not representative of all women presenting for and undergoing breast augmentation. Furthermore, this study is limited by the length of follow-up time. However, the Breast Implant Follow-up Study confirmed the findings demonstrated in the study by Alderman et al. for Satisfaction with Breasts and Psychosocial Well-being for a larger patient population with a longer follow-up time. The Breast Implant Follow-up Study is limited by the use of a single implant type and a portion of patients that were lost to follow-up.
The findings presented here have important implications for future clinical care, research, and health policy. A better understanding of what a "normal" score is will help frame BREAST-Q results on both the individual patient and the population levels. In the clinical setting, use of normative data may help a given patient and surgeon together make decisions regarding surgical indications or timing. Lastly, with regard to health policy, such as how it relates to implant regulation, there is utility in having normative patient-reported outcome scores for comparison and benchmarking purposes. The ability to demonstrate that some women present with satisfaction and well-being significantly below the norm, undergo breast augmentation (a relatively safe procedure with low complication rates), and report satisfaction and well-being significantly above the norm helps to generate increased understanding of the potential positive quality-of-life impact of this procedure.
CONCLUSIONS
Breast augmentation is a common aesthetic plastic surgery procedure, and the BREAST-Q is an important tool that is widely used for the evaluation of these patients. The normative scores presented here are an important contribution to clinical care and
PSYCHOSOCIAL INSIGHTS
By David B. Sarwer, Ph.D.
The BREAST-Q is a recently developed, psychometrically sound, patient-reported outcome measure. It is one of several new patient-reported outcome measures that hold tremendous potential to enhance the quality of research in plastic surgery that focuses on the psychosocial outcomes of both cosmetic and reconstructive procedures. The present article reports the normative data for the BREAST-Q's Augmentation module, which is specifically designed to assess outcomes of breast augmentation procedures. This article makes a valuable contribution to the literature, along with other recent articles from the suite of measures.
As the authors note, there is value in having normative values from the general population for psychometric measures. These values can provide an important context to the interpretation of results from specific patient populations. It is important, however, that normative and patient samples are similar with respect to relevant demographic and descriptive variables. While the sample size drawn from the Army of Women is sufficiently large, these women appear to be substantially older, heavier, and with larger breasts than women who typically seek cosmetic breast augmentation. These differences may make comparisons to typical breast augmentation patients difficult and may require the use of appropriate biostatistical methods to account for these differences in future studies.
While these normative values are an important contribution to this area of research, investigators are reminded that use of population norms is often seen as 
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